Full-Time
Cell Therapy Process Engineer I
Updated on 4/4/2024
Develops cell-based therapies and gene technologies
Biotechnology
Compensation Overview
$100,000 - $120,000Annually
+ Tuition Reimbursement + Student Loan Repayment + Employee Stock Purchase Plan + commuter subsidy + variety of wellness offerings
Mid
Seattle, WA, USA
Required Skills
Python
R
Requirements
- Bachelor’s in Chemical, Biological or Biomedical Engineering plus 4 yrs or MSc plus 1-2 yrs or equivalent combination of education and work experience
- 2 years of experience in biologics, viral vector, or cell therapy manufacturing
- Detail-oriented with good problem-solving, technical writing and verbal communication skills
- Ability to effectively work in multidisciplinary teams, meet deadlines, and prioritize multiple projects
- Aptitude for working in a self-driven, performance/results-oriented, fast-paced matrix environment
- Experience with cell therapy manufacturing processes and equipment including T cell isolation, lentiviral transduction, gene editing, expansion in bioreactors, cell harvest, and cryopreservation
- Well versed with cGMP requirements and working in a regulated environment
- Prior experience supporting tech transfers to external partners
- Working knowledge of statistical Design of Experiments (DoE)
- Knowledge of R, Python, JMP, Spotfire
Responsibilities
- Serve as technical person-in-plant at the contract manufacturing site providing on the floor technical support to drive manufacturing excellence
- Collect and analyze manufacturing data to identify areas for improvement
- Support investigations, participate in root cause analyses, and recommend appropriate corrective actions
- Participate in technology transfers and support implementation of operational improvements for manufacturing processes
- Support training of manufacturing personnel to implement new processes and procedures
- Draft technical documents including master batch records and components of technology transfer packages
- Function as a manufacturing subject matter expert within the MSAT organization
Sana Biotechnology, Inc. specializes in utilizing engineered cells as medicines to address various diseases and developing novel delivery technologies to repair and control genes in cells. The company also focuses on enabling broader access to therapies through scalable manufacturing solutions.
Company Stage
IPO
Total Funding
$865M
Headquarters
Seattle, Washington
Founded
2018
Growth & Insights
Headcount